News & Updates

NAFLD tied to CVD risk even in lean patients

06 Jun 2022 by

Individuals with nonalcoholic fatty liver disease (NAFLD) – despite having a lean body or healthy BMI – are at an elevated risk for peripheral vascular disease, stroke, and cardiovascular disease (CVD), a finding that surprises gastroenterologists and researchers at DDW 2022.

NAFLD tied to CVD risk even in lean patients

06 Jun 2022

Comorbidities compromise left, right atrial function

05 Jun 2022

In patients with paroxysmal atrial fibrillation, the presence of comorbidities is associated with lower left and right atrial strain, a recent study has found.

Comorbidities compromise left, right atrial function

05 Jun 2022

Elevated BP in early 40s linked to left atrial remodelling in later life

04 Jun 2022

Systolic blood pressure (BP) levels in people in their early 40s are independently related to left atrial volumes in their mid‐60s, with greater BP being relevant for left atrial remodelling later in life, according to a study.

Elevated BP in early 40s linked to left atrial remodelling in later life

04 Jun 2022

Statins cut death risk in atherosclerotic cardiovascular disease

04 Jun 2022

The use of statins helps reduce all-cause mortality in patients with atherosclerotic cardiovascular disease, especially in the first 6 months after an event, reports a recent study.

Statins cut death risk in atherosclerotic cardiovascular disease

04 Jun 2022

Brain metastasis, haemorrhage common in cardiac angiosarcoma, need early treatment

04 Jun 2022

Brain metastasis usually develops in patients with cardiac angiosarcoma (CA), and their risk of intracranial haemorrhage (IH) is high, results of a study have shown. This leads to an alarming rate of terminal haemorrhage (TH) despite normal platelet counts.

Brain metastasis, haemorrhage common in cardiac angiosarcoma, need early treatment

04 Jun 2022

Losing weight may help control cardiovascular risk in T2D

04 Jun 2022

Increasing bodyweight may aggravate cardiovascular risk in patients with type 2 diabetes (T2D), a recent Japan study has found.

Losing weight may help control cardiovascular risk in T2D

04 Jun 2022

Clopidogrel monotherapy trumps aspirin monotherapy in reducing CV events post-PCI

03 Jun 2022 by

One year after undergoing percutaneous coronary intervention (PCI), high-risk patients on clopidogrel monotherapy have a reduced risk of multiple cardiovascular (CV) outcomes compared with those on aspirin monotherapy, according to a study presented at SCAI 2022.

Clopidogrel monotherapy trumps aspirin monotherapy in reducing CV events post-PCI

03 Jun 2022

IVL maintains superiority over PTA at 1 year for peripheral artery calcification

03 Jun 2022 by

In the Disrupt PAD III trial, superior primary patency (PP) was achieved at 1 year with intravascular lithotripsy (IVL) plus a drug-coated balloon (DCB) compared with percutaneous transluminal angioplasty (PTA) + DCB, confirming the consistent safety and efficacy of IVL to facilitate a durable approach for individuals with heavily calcified femoropopliteal arteries largely without stent requirement.

IVL maintains superiority over PTA at 1 year for peripheral artery calcification

03 Jun 2022

High E/e’ tied to poor prognosis in HFrecEF

02 Jun 2022

In patients with heart failure and recovered ejection fraction (HFrecEF), having a high ratio between the peak velocity of the early wave to early diastole (E/e’) may signal worse clinical prognosis, a recent study has found.

High E/e’ tied to poor prognosis in HFrecEF

02 Jun 2022

Harmony TPV continues to show safety, efficacy for recipients at 1 year

02 Jun 2022 by

In an expanded analysis presented at SCAI 2022, recipients of the Harmony transcatheter pulmonary valve (TPV) continued to demonstrate favourable clinical and haemodynamic outcomes, confirming previous results and showing continued device success across studies and valve types at 1 year and beyond.

Harmony TPV continues to show safety, efficacy for recipients at 1 year

02 Jun 2022

News & Updates

Filter by Specialty:

Specialty:

NAFLD tied to CVD risk even in lean patients

NAFLD tied to CVD risk even in lean patients

Comorbidities compromise left, right atrial function

Comorbidities compromise left, right atrial function

Elevated BP in early 40s linked to left atrial remodelling in later life

Elevated BP in early 40s linked to left atrial remodelling in later life

Statins cut death risk in atherosclerotic cardiovascular disease

Statins cut death risk in atherosclerotic cardiovascular disease

Brain metastasis, haemorrhage common in cardiac angiosarcoma, need early treatment

Brain metastasis, haemorrhage common in cardiac angiosarcoma, need early treatment

Losing weight may help control cardiovascular risk in T2D

Losing weight may help control cardiovascular risk in T2D

Clopidogrel monotherapy trumps aspirin monotherapy in reducing CV events post-PCI

Clopidogrel monotherapy trumps aspirin monotherapy in reducing CV events post-PCI

IVL maintains superiority over PTA at 1 year for peripheral artery calcification

IVL maintains superiority over PTA at 1 year for peripheral artery calcification

High E/e’ tied to poor prognosis in HFrecEF

High E/e’ tied to poor prognosis in HFrecEF

Harmony TPV continues to show safety, efficacy for recipients at 1 year

Harmony TPV continues to show safety, efficacy for recipients at 1 year